Effects of 3-thia fatty acids on expression of some lipid related genes in Atlantic salmon (Salmo salar L.).
In this study, the effects of in vivo administration of 3-thia fatty acids (FAs) on lipid metabolism in muscle and liver of Atlantic salmon were investigated. Prior to analysis, the fish were kept in tanks supplied with 5 degrees C seawater for 20 weeks. The fish were fed fish meal and fish oil (FO)-based diets supplemented with either nothing (FO), or 0.3% and 0.6% of the 3-thia FAs dodecylthioacetic acid (DTA) and tetradecylthioacetic acid (TTA) respectively. The fish grew from an initial weight of 110 g to 220 g in the FO group and to approximately 160 g in the 3-thia FA groups. There was a significant higher mortality (66%) in fish fed 0.6% TTA than in fish fed the 0.3% DTA (15%) and FO diets (15%). None of the 3-thia FA diets affected the lipid content of the salmon muscle. The liver index, however, was significantly higher and the total liver fat content lower in the TTA group than in the FO group. Both DTA and TTA were incorporated into the lipid fraction of muscle and liver (0.4% to 0.9%). There were no major differences in the total FA composition of liver and muscle between the dietary groups; except for a small increase of n-3 polyunsaturated FAs (PUFAs) in liver of the DTA group. The mRNA expression of peroxisome proliferator-activated receptor (PPAR) alpha, apolipoprotein AI (ApoAI), apolipoprotein CII (ApoCII) and low-density lipoprotein receptor (LDL-R) was down-regulated in liver of the salmon fed 0.3% DTA. PPARalpha and ApoAI transcripts were also reduced in liver of salmon fed 0.6% TTA. Additionally, the hepatic lipoprotein lipase (LPL) mRNA level was 3.8 fold increased in TTA fish relative to the FO group. In muscle there were no significant changes in gene expression pattern of any of the genes investigated. This is the first report on the effects of 3-thia FAs on gene expression in Atlantic salmon.
Kleveland
Ellen Johanne
EJ
Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, P.O. Box 1068, Blindern, N-0316 Oslo, Norway.
Ruyter
Bente
B
Vegusdal
Anne
A
Sundvold
Hilde
H
Berge
Rolf K
RK
Gjøen
Tor
T
D042962:Acyl-CoA Oxidase / Q000378:metabolism; D000818:Animals; D016632:Apolipoprotein A-I / Q000235:genetics / Q000378:metabolism; D053304:Apolipoprotein C-II / Q000235:genetics / Q000378:metabolism; D004041:Dietary Fats / Q000008:administration & dosage / Q000494:pharmacology*; D029941:Fish Proteins / Q000235:genetics* / Q000378:metabolism; D008099:Liver / Q000201:enzymology / Q000378:metabolism; D009132:Muscles / Q000378:metabolism; D047492:Peroxisome Proliferator-Activated Receptors / Q000235:genetics / Q000378:metabolism; D011973:Receptors, LDL / Q000235:genetics / Q000378:metabolism; D020317:Salmo salar / Q000235:genetics* / Q000378:metabolism; D013440:Sulfides / Q000008:administration & dosage / Q000494:pharmacology*
D016632:Apolipoprotein A-I; D053304:Apolipoprotein C-II; D004041:Dietary Fats; D029941:Fish Proteins; D047492:Peroxisome Proliferator-Activated Receptors; D011973:Receptors, LDL; D013440:Sulfides; C064348:dodecylthioacetic acid; C062078:1-(carboxymethylthio)tetradecane; D042962:Acyl-CoA Oxidase